Skip to main content
. 2024 Sep 13;8(11):bvae160. doi: 10.1210/jendso/bvae160

Figure 1.

Figure 1.

Figure 1 incorporates a few studies examining BMD changes observed with romosozumab when used before/after other osteoporosis agents. Given differing study designs, the figure is included as a visual representation of different treatment sequences explored in the studies rather than as a direct comparison of outcomes.